Amyloid Solution

Amyloid Solution Inc. is a Korea-based clinical-stage biotech company developing innovative therapeutics and blood-based diagnostics for Alzheimer’s disease (AD). Our therapeutic programs target the chemical-driven clearance of misfolded proteins and the restoration of glial homeostasis to address AD’s complex pathology. In diagnostics, we are advancing a fluorescent probe-based platform for accessible and accurate detection of Aβ42 oligomers in blood, supporting early diagnosis and patient stratification. From target discovery to translational research, we are committed to scientific innovation and global collaboration.

Address

Seongnam-si
Gyeonggi-do
South Korea
Loading